This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly
Nature Communications Open Access 18 October 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rubino, F. et al. Diabetes Care 39, 861–877 (2016).
Wynne, K. et al. Diabetes 54, 2390–2395 (2005).
Bagger, J.I. et al. J. Clin. Endocrinol. Metab. 100, 4541–4552 (2015).
Day, J.W. et al. Nat. Chem. Biol. 10, 749–757 (2009).
Finan, B. et al. Sci. Transl. Med. 5, 209ra151 (2013).
Finan, B. et al. Nat. Med. 21, 27–36 (2015).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakradhar, S. All in one: Researchers create combination drugs for diabetes and obesity. Nat Med 22, 694–696 (2016). https://doi.org/10.1038/nm0716-694
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0716-694
This article is cited by
-
Prediction of drug combination effects with a minimal set of experiments
Nature Machine Intelligence (2019)
-
Controlling the bioactivity of a peptide hormone in vivo by reversible self-assembly
Nature Communications (2017)